-
1
-
-
84858383401
-
Diabetes mellitus and the β cell: The last ten years
-
Ashcroft FM, Rorsman P. Diabetes mellitus and the β cell: the last ten years. Cell 148: 1160-1171, 2012.
-
(2012)
Cell
, vol.148
, pp. 1160-1171
-
-
Ashcroft, F.M.1
Rorsman, P.2
-
2
-
-
80052716132
-
Detailed protocol for evaluation of dynamic perifusion of human islets to assess β-cell function
-
Bentsi-Barnes K, Doyle ME, Abad D, Kandeel F, Al-Abdullah I. Detailed protocol for evaluation of dynamic perifusion of human islets to assess β-cell function. Islets 3: 284-290, 2011.
-
(2011)
Islets
, vol.3
, pp. 284-290
-
-
Bentsi-Barnes, K.1
Doyle, M.E.2
Abad, D.3
Kandeel, F.4
Al-Abdullah, I.5
-
3
-
-
0033623530
-
i abnormalities in human pancreatic islets: Important role of overstimulation
-
i abnormalities in human pancreatic islets: important role of overstimulation. Diabetes 49: 1840-1848, 2000.
-
(2000)
Diabetes
, vol.49
, pp. 1840-1848
-
-
Björklund, A.1
Lansner, A.2
Grill, V.E.3
-
4
-
-
0014789878
-
Portal and peripheral vein immunoreactive insulin concentrations before and after glucose infusion
-
Blackard WG, Nelson NC. Portal and peripheral vein immunoreactive insulin concentrations before and after glucose infusion. Diabetes 19: 302-306, 1970.
-
(1970)
Diabetes
, vol.19
, pp. 302-306
-
-
Blackard, W.G.1
Nelson, N.C.2
-
5
-
-
0037312840
-
Altered homeostatic adaptation of first-and second-phase β-cell secretion in the offspring of patients with type 2 diabetes: Studies with a minimal model to assess β-cell function
-
Bonadonna RC, Stumvoll M, Fritsche A, Muggeo M, Häring H, Bonora E, van Haeften TW. Altered homeostatic adaptation of first-and second-phase β-cell secretion in the offspring of patients with type 2 diabetes: studies with a minimal model to assess β-cell function. Diabetes 52: 470-480, 2003.
-
(2003)
Diabetes
, vol.52
, pp. 470-480
-
-
Bonadonna, R.C.1
Stumvoll, M.2
Fritsche, A.3
Muggeo, M.4
Häring, H.5
Bonora, E.6
van Haeften, T.W.7
-
6
-
-
0034886245
-
GLP-1-induced alterations in the glucose-stimulated insulin secretory dose-response curve
-
Brandt A, Katschinski M, Arnold R, Polonsky KS, Göke B, Byrne MM. GLP-1-induced alterations in the glucose-stimulated insulin secretory dose-response curve. Am J Physiol Endocrinol Metab 281: E242-E247, 2001.
-
(2001)
Am J Physiol Endocrinol Metab
, vol.281
, pp. E242-E247
-
-
Brandt, A.1
Katschinski, M.2
Arnold, R.3
Polonsky, K.S.4
Göke, B.5
Byrne, M.M.6
-
7
-
-
0017236889
-
Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests
-
Brunzell JD, Robertson RP, Lerner RL, Hazzard WR, Ensinck JW, Bierman EL, Porte D Jr. Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab 42: 222-229, 1976.
-
(1976)
J Clin Endocrinol Metab
, vol.42
, pp. 222-229
-
-
Brunzell, J.D.1
Robertson, R.P.2
Lerner, R.L.3
Hazzard, W.R.4
Ensinck, J.W.5
Bierman, E.L.6
Porte, D.7
-
8
-
-
79959281722
-
A local glucose-and oxygen concentration-based insulin secretion model for pancreatic islets
-
Buchwald P. A local glucose-and oxygen concentration-based insulin secretion model for pancreatic islets. Theor Biol Med Model 8: 20, 2011.
-
(2011)
Theor Biol Med Model
, vol.8
, pp. 20
-
-
Buchwald, P.1
-
9
-
-
4143081356
-
First-phase insulin secretion: Does it exist in real life? Considerations on shape and function
-
Caumo A, Luzi L. First-phase insulin secretion: does it exist in real life? Considerations on shape and function. Am J Physiol Endocrinol Metab 287: E371-E385, 2004.
-
(2004)
Am J Physiol Endocrinol Metab
, vol.287
, pp. E371-E385
-
-
Caumo, A.1
Luzi, L.2
-
10
-
-
0014095480
-
The plasma insulin response to glucose infusion in healthy subjects and in diabetes mellitus
-
Cerasi E, Luft R. The plasma insulin response to glucose infusion in healthy subjects and in diabetes mellitus. Acta Endocrinol 55: 278-304, 1967.
-
(1967)
Acta Endocrinol
, vol.55
, pp. 278-304
-
-
Cerasi, E.1
Luft, R.2
-
11
-
-
65549119098
-
Degradation of cAMP-responsive element-binding protein by the ubiqui-tin-proteasome pathway contributes to glucotoxicity in β-cells and human pancreatic islets
-
Costes S, Vandewalle B, Tourrel-Cuzin C, Broca C, Linck N, Bertrand G, Kerr-Conte J, Portha B, Pattou F, Bockaert J, Dalle S. Degradation of cAMP-responsive element-binding protein by the ubiqui-tin-proteasome pathway contributes to glucotoxicity in β-cells and human pancreatic islets. Diabetes 58: 1105-1115, 2009.
-
(2009)
Diabetes
, vol.58
, pp. 1105-1115
-
-
Costes, S.1
Vandewalle, B.2
Tourrel-Cuzin, C.3
Broca, C.4
Linck, N.5
Bertrand, G.6
Kerr-Conte, J.7
Portha, B.8
Pattou, F.9
Bockaert, J.10
Dalle, S.11
-
12
-
-
0014336473
-
Dynamics of insulin secretion by the perfused rat pancreas
-
Curry DL, Bennett LL, Grodsky GM. Dynamics of insulin secretion by the perfused rat pancreas. Endocrinology 83: 572-584, 1968.
-
(1968)
Endocrinology
, vol.83
, pp. 572-584
-
-
Curry, D.L.1
Bennett, L.L.2
Grodsky, G.M.3
-
13
-
-
0026033901
-
Abnormal sensitivity to glucose of human islets cultured in a high glucose medium: Partial reversibility after an additional culture in a normal glucose medium
-
Davalli AM, Ricordi C, Socci C, Braghi S, Bertuzzi F, Fattor B, Di Carlo V, Pontiroli AE, Pozza G. Abnormal sensitivity to glucose of human islets cultured in a high glucose medium: partial reversibility after an additional culture in a normal glucose medium. J Clin Endocrinol Metab 72: 202-208, 1991.
-
(1991)
J Clin Endocrinol Metab
, vol.72
, pp. 202-208
-
-
Davalli, A.M.1
Ricordi, C.2
Socci, C.3
Braghi, S.4
Bertuzzi, F.5
Fattor, B.6
Di Carlo, V.7
Pontiroli, A.E.8
Pozza, G.9
-
14
-
-
0015419972
-
Insulin response to glucose, tolbutamide, secretin, and isoprenaline in maturity-onset diabetes mellitus
-
Deckert T, Lauridsen UB, Madsen SN, Mogensen P. Insulin response to glucose, tolbutamide, secretin, and isoprenaline in maturity-onset diabetes mellitus. Dan Med Bull 19: 222-226, 1972.
-
(1972)
Dan Med Bull
, vol.19
, pp. 222-226
-
-
Deckert, T.1
Lauridsen, U.B.2
Madsen, S.N.3
Mogensen, P.4
-
15
-
-
0034944773
-
The importance of first-phase insulin secretion: Implications for the therapy of type 2 diabetes mellitus
-
Del Prato S, Tiengo A. The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus. Diabetes Metab Res Rev 17: 164-174, 2001.
-
(2001)
Diabetes Metab Res Rev
, vol.17
, pp. 164-174
-
-
Del Prato, S.1
Tiengo, A.2
-
16
-
-
0029833117
-
Stable and diffusible pools of nucleotides in pancreatic islet cells
-
Detimary P, Jonas JC, Henquin JC. Stable and diffusible pools of nucleotides in pancreatic islet cells. Endocrinology 137: 4671-4676, 1996.
-
(1996)
Endocrinology
, vol.137
, pp. 4671-4676
-
-
Detimary, P.1
Jonas, J.C.2
Henquin, J.C.3
-
17
-
-
83455197122
-
Glucokinase activation repairs defective bioenergetics of islets of Langerhans isolated from type 2 diabetics
-
Doliba NM, Qin W, Najafi H, Liu C, Buettger CW, Sotiris J, Collins HW, Li C, Stanley CA, Wilson DF, Grimsby J, Sarabu R, Naji A, Matschinsky FM. Glucokinase activation repairs defective bioenergetics of islets of Langerhans isolated from type 2 diabetics. Am J Physiol Endocrinol Metab 302: E87-E102, 2012.
-
(2012)
Am J Physiol Endocrinol Metab
, vol.302
, pp. E87-E102
-
-
Doliba, N.M.1
Qin, W.2
Najafi, H.3
Liu, C.4
Buettger, C.W.5
Sotiris, J.6
Collins, H.W.7
Li, C.8
Stanley, C.A.9
Wilson, D.F.10
Grimsby, J.11
Sarabu, R.12
Naji, A.13
Matschinsky, F.M.14
-
18
-
-
33644768417
-
A simple method using a polymethylpenten chamber for isolation of human pancreatic islets
-
Dufrane D, Goebbels RM, Guiot Y, Squifflet JP, Henquin JC, Gianello P. A simple method using a polymethylpenten chamber for isolation of human pancreatic islets. Pancreas 30: e51-e59, 2005.
-
(2005)
Pancreas
, vol.30
, pp. e51-e59
-
-
Dufrane, D.1
Goebbels, R.M.2
Guiot, Y.3
Squifflet, J.P.4
Henquin, J.C.5
Gianello, P.6
-
19
-
-
84879396514
-
Small human islets comprised of more β-cells with higher insulin content than large islets
-
Farhat B, Almelkar A, Ramachandran K, Williams SJ, Huang HH, Zamierowksi D, Novikova L, Stehno-Bittel L. Small human islets comprised of more β-cells with higher insulin content than large islets. Islets 5: 87-94, 2013.
-
(2013)
Islets
, vol.5
, pp. 87-94
-
-
Farhat, B.1
Almelkar, A.2
Ramachandran, K.3
Williams, S.J.4
Huang, H.H.5
Zamierowksi, D.6
Novikova, L.7
Stehno-Bittel, L.8
-
20
-
-
0022452250
-
Effects of short-term hyperglycemia on insulin secretion in normal humans
-
Ferner RE, Ashworth L, Tronier B, Alberti KG. Effects of short-term hyperglycemia on insulin secretion in normal humans. Am J Physiol Endocrinol Metab 250: E655-E661, 1986.
-
(1986)
Am J Physiol Endocrinol Metab
, vol.250
, pp. E655-E661
-
-
Ferner, R.E.1
Ashworth, L.2
Tronier, B.3
Alberti, K.G.4
-
21
-
-
2942598368
-
Beta cell function and its relation to insulin action in humans: A critical appraisal
-
Ferrannini E, Mari A. Beta cell function and its relation to insulin action in humans: a critical appraisal. Diabetologia 47: 943-956, 2004.
-
(2004)
Diabetologia
, vol.47
, pp. 943-956
-
-
Ferrannini, E.1
Mari, A.2
-
22
-
-
0036315001
-
Relationships among age, proinsulin conversion, and β-cell function in nondiabetic humans
-
Fritsche A, Madaus A, Stefan N, Tschritter O, Maerker E, Teigeler A, Häring H, Stumvoll M. Relationships among age, proinsulin conversion, and β-cell function in nondiabetic humans. Diabetes 51, Suppl 1: S234-S239, 2002.
-
(2002)
Diabetes
, vol.51
, pp. S234-S239
-
-
Fritsche, A.1
Madaus, A.2
Stefan, N.3
Tschritter, O.4
Maerker, E.5
Teigeler, A.6
Häring, H.7
Stumvoll, M.8
-
23
-
-
0036314864
-
Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes?
-
Gerich JE. Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes? Diabetes 51, Suppl 1: S117-S121, 2002.
-
(2002)
Diabetes
, vol.51
, pp. S117-S121
-
-
Gerich, J.E.1
-
24
-
-
4143057100
-
Loss of beta cell function as fasting glucose increases in the non-diabetic range
-
Godsland IF, Jeffs JA, Johnston DG. Loss of beta cell function as fasting glucose increases in the non-diabetic range. Diabetologia 47: 1157-1166, 2004.
-
(2004)
Diabetologia
, vol.47
, pp. 1157-1166
-
-
Godsland, I.F.1
Jeffs, J.A.2
Johnston, D.G.3
-
25
-
-
0021952031
-
Properties of isolated human islets of Langerhans: Insulin secretion, glucose oxidation and protein phosphorylation
-
Harrison DE, Christie MR, Gray DW. Properties of isolated human islets of Langerhans: insulin secretion, glucose oxidation and protein phosphorylation. Diabetologia 28: 99-103, 1985.
-
(1985)
Diabetologia
, vol.28
, pp. 99-103
-
-
Harrison, D.E.1
Christie, M.R.2
Gray, D.W.3
-
26
-
-
0027994543
-
2+ signalling and insulin release in human pancreatic beta cells
-
2+ signalling and insulin release in human pancreatic beta cells. Diabetologia 37, Suppl 2: S11-S20, 1994.
-
(1994)
Diabetologia
, vol.37
, pp. S11-S20
-
-
Hellman, B.1
Gylfe, E.2
Bergsten, P.3
Grapengiesser, E.4
Lund, P.E.5
Berts, A.6
Tengholm, A.7
Pipeleers, D.G.8
Ling, Z.9
-
27
-
-
33845541249
-
Nutrient control of insulin secretion in isolated normal human islets
-
Henquin JC, Dufrane D, Nenquin M. Nutrient control of insulin secretion in isolated normal human islets. Diabetes 55: 3470-3477, 2006.
-
(2006)
Diabetes
, vol.55
, pp. 3470-3477
-
-
Henquin, J.C.1
Dufrane, D.2
Nenquin, M.3
-
28
-
-
0036318364
-
Signals and pools underlying biphasic insulin secretion
-
Henquin JC, Ishiyama N, Nenquin M, Ravier MA, Jonas JC. Signals and pools underlying biphasic insulin secretion. Diabetes 51, Suppl 1: S60-S67, 2002.
-
(2002)
Diabetes
, vol.51
, pp. S60-S67
-
-
Henquin, J.C.1
Ishiyama, N.2
Nenquin, M.3
Ravier, M.A.4
Jonas, J.C.5
-
30
-
-
0023229503
-
+ on arginine stimulation of insulin release in isolated mouse islets
-
+ on arginine stimulation of insulin release in isolated mouse islets. Diabetologia 30: 659-665, 1987.
-
(1987)
Diabetologia
, vol.30
, pp. 659-665
-
-
Hermans, M.P.1
Schmeer, W.2
Henquin, J.C.3
-
31
-
-
0016582510
-
Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood
-
Horwitz DL, Starr JI, Mako ME, Blackard WG, Rubenstein AH. Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood. J Clin Invest 55: 1278-1283, 1975.
-
(1975)
J Clin Invest
, vol.55
, pp. 1278-1283
-
-
Horwitz, D.L.1
Starr, J.I.2
Mako, M.E.3
Blackard, W.G.4
Rubenstein, A.H.5
-
32
-
-
0024354876
-
Similar reduction of first-and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapy
-
Hosker JP, Rudenski AS, Burnett MA, Matthews DR, Turner RC. Similar reduction of first-and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapy. Metabolism 38: 767-772, 1989.
-
(1989)
Metabolism
, vol.38
, pp. 767-772
-
-
Hosker, J.P.1
Rudenski, A.S.2
Burnett, M.A.3
Matthews, D.R.4
Turner, R.C.5
-
33
-
-
0033347050
-
Prolonged exposure of human beta-cells to high glucose increases their release of proinsulin during acute stimulation with glucose or arginine
-
Hostens K, Ling Z, Van Schravendijk C, Pipeleers D. Prolonged exposure of human beta-cells to high glucose increases their release of proinsulin during acute stimulation with glucose or arginine. J Clin Endocrinol Metab 84: 1386-1390, 1999.
-
(1999)
J Clin Endocrinol Metab
, vol.84
, pp. 1386-1390
-
-
Hostens, K.1
Ling, Z.2
Van Schravendijk, C.3
Pipeleers, D.4
-
34
-
-
33645074184
-
Dual mechanism of the potentiation by glucose of insulin secretion induced by arginine and tolbutamide in mouse islets
-
Ishiyama N, Ravier MA, Henquin JC. Dual mechanism of the potentiation by glucose of insulin secretion induced by arginine and tolbutamide in mouse islets. Am J Physiol Endocrinol Metab 290: E540-E549, 2006.
-
(2006)
Am J Physiol Endocrinol Metab
, vol.290
, pp. E540-E549
-
-
Ishiyama, N.1
Ravier, M.A.2
Henquin, J.C.3
-
35
-
-
0031154101
-
Alterations in the glucose-stimulated insulin secretory dose-response curve and in insulin clearance in nondiabetic insulin-resistant individuals
-
Jones CN, Pei D, Staris P, Polonsky KS, Chen YD, Reaven GM. Alterations in the glucose-stimulated insulin secretory dose-response curve and in insulin clearance in nondiabetic insulin-resistant individuals. J Clin Endocrinol Metab 82: 1834-1838, 1997.
-
(1997)
J Clin Endocrinol Metab
, vol.82
, pp. 1834-1838
-
-
Jones, C.N.1
Pei, D.2
Staris, P.3
Polonsky, K.S.4
Chen, Y.D.5
Reaven, G.M.6
-
36
-
-
0030662718
-
Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM
-
Kahn SE, Halban PA. Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM. Diabetes 46: 1725-1732, 1997.
-
(1997)
Diabetes
, vol.46
, pp. 1725-1732
-
-
Kahn, S.E.1
Halban, P.A.2
-
37
-
-
0022999213
-
Selective unresponsiveness of pancreatic beta-cells to acute sulfonylurea stimulation during sulfonylurea therapy in NIDDM
-
Karam JH, Sanz N, Salamon E, Nolte MS. Selective unresponsiveness of pancreatic beta-cells to acute sulfonylurea stimulation during sulfonylurea therapy in NIDDM. Diabetes 35: 1314-1320, 1986.
-
(1986)
Diabetes
, vol.35
, pp. 1314-1320
-
-
Karam, J.H.1
Sanz, N.2
Salamon, E.3
Nolte, M.S.4
-
38
-
-
0141755328
-
A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes
-
Kashyap S, Belfort R, Gastaldelli A, Pratipanawatr T, Berria R, Pratipanawatr W, Bajaj M, Mandarino L, DeFronzo R, Cusi K. A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 52: 2461-2474, 2003.
-
(2003)
Diabetes
, vol.52
, pp. 2461-2474
-
-
Kashyap, S.1
Belfort, R.2
Gastaldelli, A.3
Pratipanawatr, T.4
Berria, R.5
Pratipanawatr, W.6
Bajaj, M.7
Mandarino, L.8
DeFronzo, R.9
Cusi, K.10
-
39
-
-
84926314979
-
Human islet preparations distributed for research exhibit a variety of insulin-secretory profiles
-
Kayton NS, Poffenberger G, Henske J, Dai C, Thompson C, Aramandla R, Shostak A, Nicholson W, Brissova M, Bush WS, Powers AC. Human islet preparations distributed for research exhibit a variety of insulin-secretory profiles. Am J Physiol Endocrinol Metab 308: E592-E602, 2015.
-
(2015)
Am J Physiol Endocrinol Metab
, vol.308
, pp. E592-E602
-
-
Kayton, N.S.1
Poffenberger, G.2
Henske, J.3
Dai, C.4
Thompson, C.5
Aramandla, R.6
Shostak, A.7
Nicholson, W.8
Brissova, M.9
Bush, W.S.10
Powers, A.C.11
-
40
-
-
77951828904
-
Upgrading pretransplant human islet culture technology requires human serum combined with media renewal
-
Kerr-Conte J, Vandewalle B, Moerman E, Lukowiak B, Gmyr V, Arnalsteen L, Caiazzo R, Sterkers A, Hubert T, Vantyghem MC, Pattou F. Upgrading pretransplant human islet culture technology requires human serum combined with media renewal. Transplantation 89: 1154-1160, 2010.
-
(2010)
Transplantation
, vol.89
, pp. 1154-1160
-
-
Kerr-Conte, J.1
Vandewalle, B.2
Moerman, E.3
Lukowiak, B.4
Gmyr, V.5
Arnalsteen, L.6
Caiazzo, R.7
Sterkers, A.8
Hubert, T.9
Vantyghem, M.C.10
Pattou, F.11
-
41
-
-
0015416752
-
Perifusion of isolated rat islets in vitro. Participation of the microtubular system in the biphasic release of insulin
-
Lacy PE, Walker MM, Fink CJ. Perifusion of isolated rat islets in vitro. Participation of the microtubular system in the biphasic release of insulin. Diabetes 21: 987-998, 1972.
-
(1972)
Diabetes
, vol.21
, pp. 987-998
-
-
Lacy, P.E.1
Walker, M.M.2
Fink, C.J.3
-
42
-
-
33847380696
-
Superiority of small islets in human islet transplantation
-
Lehmann R, Zuellig RA, Kugelmeier P, Baenninger PB, Moritz W, Perren A, Clavien PA, Weber M, Spinas GA. Superiority of small islets in human islet transplantation. Diabetes 56: 594-603, 2007.
-
(2007)
Diabetes
, vol.56
, pp. 594-603
-
-
Lehmann, R.1
Zuellig, R.A.2
Kugelmeier, P.3
Baenninger, P.B.4
Moritz, W.5
Perren, A.6
Clavien, P.A.7
Weber, M.8
Spinas, G.A.9
-
43
-
-
0018460451
-
Insulin secretion by isolated perfused rat and mouse pancreas
-
Lenzen S. Insulin secretion by isolated perfused rat and mouse pancreas. Am J Physiol Endocrinol Metab Gastrointest Physiol 236: E391-E400, 1979.
-
(1979)
Am J Physiol Endocrinol Metab Gastrointest Physiol
, vol.236
, pp. E391-E400
-
-
Lenzen, S.1
-
44
-
-
80054091845
-
Reversal of type 2 diabetes: Normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol
-
Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 54: 2506-2514, 2011.
-
(2011)
Diabetologia
, vol.54
, pp. 2506-2514
-
-
Lim, E.L.1
Hollingsworth, K.G.2
Aribisala, B.S.3
Chen, M.J.4
Mathers, J.C.5
Taylor, R.6
-
45
-
-
0028304439
-
Pulsatile insulin secretion from isolated human pancreatic islets
-
Marchetti P, Scharp DW, Mclear M, Gingerich R, Finke E, Olack B, Swanson C, Giannarelli R, Navalesi R, Lacy PE. Pulsatile insulin secretion from isolated human pancreatic islets. Diabetes 43: 827-830, 1994.
-
(1994)
Diabetes
, vol.43
, pp. 827-830
-
-
Marchetti, P.1
Scharp, D.W.2
McLear, M.3
Gingerich, R.4
Finke, E.5
Olack, B.6
Swanson, C.7
Giannarelli, R.8
Navalesi, R.9
Lacy, P.E.10
-
46
-
-
44649144546
-
Relationships between insulin secretion after intravenous and oral glucose administration in subjects with glucose tolerance ranging from normal to overt diabetes
-
Mari A, Tura A, Pacini G, Kautzky-Willer A, Ferrannini E. Relationships between insulin secretion after intravenous and oral glucose administration in subjects with glucose tolerance ranging from normal to overt diabetes. Diabet Med 25: 671-677, 2008.
-
(2008)
Diabet Med
, vol.25
, pp. 671-677
-
-
Mari, A.1
Tura, A.2
Pacini, G.3
Kautzky-Willer, A.4
Ferrannini, E.5
-
47
-
-
0344258475
-
Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose
-
Marshak S, Leibowitz G, Bertuzzi F, Socci C, Kaiser N, Gross DJ, Cerasi E, Melloul D. Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose. Diabetes 48: 1230-1236, 1999.
-
(1999)
Diabetes
, vol.48
, pp. 1230-1236
-
-
Marshak, S.1
Leibowitz, G.2
Bertuzzi, F.3
Socci, C.4
Kaiser, N.5
Gross, D.J.6
Cerasi, E.7
Melloul, D.8
-
48
-
-
0029657938
-
i oscillations in single human pancreatic islets
-
i oscillations in single human pancreatic islets. Cell Calcium 20: 409-414, 1996.
-
(1996)
Cell Calcium
, vol.20
, pp. 409-414
-
-
Martín, F.1
Soria, B.2
-
49
-
-
34248137479
-
Human insulin vesicle dynamics during pulsatile secretion
-
Michael DJ, Xiong W, Geng X, Drain P, Chow RH. Human insulin vesicle dynamics during pulsatile secretion. Diabetes 56: 1277-1288, 2007.
-
(2007)
Diabetes
, vol.56
, pp. 1277-1288
-
-
Michael, D.J.1
Xiong, W.2
Geng, X.3
Drain, P.4
Chow, R.H.5
-
50
-
-
0026043872
-
Prolonged maximal stimulation of insulin secretion in healthy subjects does not provoke preferential release of proinsulin
-
Nauck MA, Siegel EG, Creutzfeldt W. Prolonged maximal stimulation of insulin secretion in healthy subjects does not provoke preferential release of proinsulin. Pancreas 6: 645-652, 1991.
-
(1991)
Pancreas
, vol.6
, pp. 645-652
-
-
Nauck, M.A.1
Siegel, E.G.2
Creutzfeldt, W.3
-
51
-
-
0036314212
-
Modeling phasic insulin release: Immediate and time-dependent effects of glucose
-
Nesher R, Cerasi E. Modeling phasic insulin release: immediate and time-dependent effects of glucose. Diabetes 51, Suppl 1: S53-S59, 2002.
-
(2002)
Diabetes
, vol.51
, pp. S53-S59
-
-
Nesher, R.1
Cerasi, E.2
-
52
-
-
82155198455
-
Chronic reduction of fasting glycemia with insulin glargine improves first-and second-phase insulin secretion in patients with type 2 diabetes
-
Pennartz C, Schenker N, Menge BA, Schmidt WE, Nauck MA, Meier JJ. Chronic reduction of fasting glycemia with insulin glargine improves first-and second-phase insulin secretion in patients with type 2 diabetes. Diabetes Care 34: 2048-2053, 2011.
-
(2011)
Diabetes Care
, vol.34
, pp. 2048-2053
-
-
Pennartz, C.1
Schenker, N.2
Menge, B.A.3
Schmidt, W.E.4
Nauck, M.A.5
Meier, J.J.6
-
53
-
-
0019406016
-
The regulation of glucose-induced insulin secretion by pre-stimulus glucose level and tolbutamide in normal man
-
Pfeifer MA, Graf RJ, Halter JB, Porte D Jr. The regulation of glucose-induced insulin secretion by pre-stimulus glucose level and tolbutamide in normal man. Diabetologia 21: 198-205, 1981.
-
(1981)
Diabetologia
, vol.21
, pp. 198-205
-
-
Pfeifer, M.A.1
Graf, R.J.2
Halter, J.B.3
Porte, D.4
-
54
-
-
0242684706
-
Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery
-
Polyzogopoulou EV, Kalfarentzos F, Vagenakis AG, Alexandrides TK. Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. Diabetes 52: 1098-1103, 2003.
-
(2003)
Diabetes
, vol.52
, pp. 1098-1103
-
-
Polyzogopoulou, E.V.1
Kalfarentzos, F.2
Vagenakis, A.G.3
Alexandrides, T.K.4
-
55
-
-
0026110135
-
Beta-cells in type II diabetes mellitus
-
Porte D Jr. Beta-cells in type II diabetes mellitus. Diabetes 40: 166 -180, 1991.
-
(1991)
Diabetes
, vol.40
, pp. 166-180
-
-
Porte, D.1
-
56
-
-
0034884627
-
The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus
-
Pratley RE, Weyer C. The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus. Diabetologia 44: 929 -945, 2001.
-
(2001)
Diabetologia
, vol.44
, pp. 929-945
-
-
Pratley, R.E.1
Weyer, C.2
-
57
-
-
53549093011
-
Pancreatic β-cell mass in European subjects with type 2 diabetes
-
Rahier J, Guiot Y, Goebbels RM, Sempoux C, Henquin JC. Pancreatic β-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab 10, Suppl 4: 32-42, 2008.
-
(2008)
Diabetes Obes Metab
, vol.10
, pp. 32-42
-
-
Rahier, J.1
Guiot, Y.2
Goebbels, R.M.3
Sempoux, C.4
Henquin, J.C.5
-
59
-
-
84873670723
-
Regulation of insulin secretion in human pancreatic islets
-
Rorsman P, Braun M. Regulation of insulin secretion in human pancreatic islets. Annu Rev Physiol 75: 155-179, 2013.
-
(2013)
Annu Rev Physiol
, vol.75
, pp. 155-179
-
-
Rorsman, P.1
Braun, M.2
-
60
-
-
0042879951
-
Insulin granule dynamics in pancreatic beta cells
-
Rorsman P, Renström E. Insulin granule dynamics in pancreatic beta cells. Diabetologia 46: 1029-1045, 2003.
-
(2003)
Diabetologia
, vol.46
, pp. 1029-1045
-
-
Rorsman, P.1
Renström, E.2
-
61
-
-
64749102777
-
First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery
-
Salinari S, Bertuzzi A, Asnaghi S, Guidone C, Manco M, Mingrone G. First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery. Diabetes Care 32: 375-380, 2009.
-
(2009)
Diabetes Care
, vol.32
, pp. 375-380
-
-
Salinari, S.1
Bertuzzi, A.2
Asnaghi, S.3
Guidone, C.4
Manco, M.5
Mingrone, G.6
-
62
-
-
79957900616
-
Dynamics of insulin secretion and the clinical implications for obesity and diabetes
-
Seino S, Shibasaki T, Minami K. Dynamics of insulin secretion and the clinical implications for obesity and diabetes. J Clin Invest 121: 2118-2125, 2011.
-
(2011)
J Clin Invest
, vol.121
, pp. 2118-2125
-
-
Seino, S.1
Shibasaki, T.2
Minami, K.3
-
63
-
-
4143118847
-
Hypothesis: One rate-limiting step controls the magnitude of both phases of glucose-stimulated insulin secretion
-
Straub SG, Sharp GW. Hypothesis: one rate-limiting step controls the magnitude of both phases of glucose-stimulated insulin secretion. Am J Physiol Cell Physiol 287: C565-C571, 2004.
-
(2004)
Am J Physiol Cell Physiol
, vol.287
, pp. C565-C571
-
-
Straub, S.G.1
Sharp, G.W.2
-
64
-
-
0036318015
-
Effect of acute hyperglycemia on insulin secretion in humans
-
Toschi E, Camastra S, Gastaldelli A, Mari A, Ferrannini E, Natali A. Effect of acute hyperglycemia on insulin secretion in humans. Diabetes 51, Suppl 1: S130-S133, 2002.
-
(2002)
Diabetes
, vol.51
, pp. S130-S133
-
-
Toschi, E.1
Camastra, S.2
Gastaldelli, A.3
Mari, A.4
Ferrannini, E.5
Natali, A.6
-
65
-
-
0020086355
-
The defective glucose sensitivity of the B cell in non insulin dependent diabetes. Improvement after twenty hours of normoglycaemia
-
Vague P, Moulin JP. The defective glucose sensitivity of the B cell in non insulin dependent diabetes. Improvement after twenty hours of normoglycaemia. Metabolism 31: 139-142, 1982.
-
(1982)
Metabolism
, vol.31
, pp. 139-142
-
-
Vague, P.1
Moulin, J.P.2
-
66
-
-
0023634652
-
Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance
-
Ward WK, LaCava EC, Paquette TL, Beard JC, Wallum BJ, Porte D Jr. Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia 30: 698-702, 1987.
-
(1987)
Diabetologia
, vol.30
, pp. 698-702
-
-
Ward, W.K.1
LaCava, E.C.2
Paquette, T.L.3
Beard, J.C.4
Wallum, B.J.5
Porte, D.6
-
67
-
-
70350330155
-
Towards better understanding of the contributions of overwork and glucotoxicity to the beta-cell inadequacy of type 2 diabetes
-
Weir GC, Marselli L, Marchetti P, Katsuta H, Jung MH, Bonner-Weir S. Towards better understanding of the contributions of overwork and glucotoxicity to the beta-cell inadequacy of type 2 diabetes. Diabetes Obes Metab 11, Suppl 4: 82-90, 2009.
-
(2009)
Diabetes Obes Metab
, vol.11
, pp. 82-90
-
-
Weir, G.C.1
Marselli, L.2
Marchetti, P.3
Katsuta, H.4
Jung, M.H.5
Bonner-Weir, S.6
-
68
-
-
43849105857
-
Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: A multicentre randomised parallel-group trial
-
Weng J, Li Y, Xu W, Shi L, Zhang Q, Zhu D, Hu Y, Zhou Z, Yan X, Tian H, Ran X, Luo Z, Xian J, Yan L, Li F, Zeng L, Chen Y, Yang L, Yan S, Liu J, Li M, Fu Z, Cheng H. Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial. Lancet 371: 1753-1760, 2008.
-
(2008)
Lancet
, vol.371
, pp. 1753-1760
-
-
Weng, J.1
Li, Y.2
Xu, W.3
Shi, L.4
Zhang, Q.5
Zhu, D.6
Hu, Y.7
Zhou, Z.8
Yan, X.9
Tian, H.10
Ran, X.11
Luo, Z.12
Xian, J.13
Yan, L.14
Li, F.15
Zeng, L.16
Chen, Y.17
Yang, L.18
Yan, S.19
Liu, J.20
Li, M.21
Fu, Z.22
Cheng, H.23
more..
|